The charcot joint osteoarthropathy: a case report


  • Putu Aditya Dwipayana General Practitioner, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia
  • Dewi Catur Wulandari Endocrinologist, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia



Charcot osteoarthropathy, Diabetes mellitus


The Charcot Joint Osteoarthropathy also referred as Charcot foot syndrome is a serious lower limb-threatening complication of diabetes. A patient was diagnosed with Charcot joint osteoarthropathy (COA) and found to have uncontrolled Diabetes Mellitus since more than 10 years. This case is crucial considering that Diabetes mellitus is a common case that we encounter, but the consequences of not being controlled can lead to serious complications. Accurate diagnosis is not always easy and can be a considerable clinical challenge. It needs to be differentiated from other conditions that has similar symptoms. Early diagnosis and initiation of treatment is crucial to avoid devastating and permanent complications.

Author Biographies

Putu Aditya Dwipayana, General Practitioner, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

General Practitioner. Wangaya General Hospital.

Dewi Catur Wulandari, Endocrinologist, Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

Endocrinologist. Departemen of Internal Medicine. Wangaya General Hospital.


Ray CW, Catur WD. Charcot Neuropathic Osteoarthropathy with Hypoalbuminemia: A Case Report. International Journal of Science and Research. 2018.;2319-7064.

Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes. 2011;2(5):59-65.

Kaynak GK, Birsel O, Gu¨ ven MF, Ogut T. An overview of the Charcot foot pathophysiology. Diabetic Foot & Ankle. 2013;4:21117.

Rogers LC, Frykberg RG, Armstrong DG, Andrew BJM, Michael E, Ha van Georges, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-9.

Trepman E, Nihal A, Pinzur MS. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46-63.

Gough A, Abraha H, Li F, Abraha H, Watkins PJ, Moniz C, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14(7):527-31.

Stevens MJ, Edmonds ME, Foster AVM. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35:148-54.

Grant WP, Sullivan R, Sonenshine DE. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36(4):272-330.

Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085-96.

William J. Jeffcoate. Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev 2008; 24 (Suppl 1): S62–S65.

Ndip A, Williams A, Jude EB, Serracino-Inglott F, Richardson S, Smyth JV et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60(8):2187-96.

Uccioli L, Sinistro A, Almerighi C, Ciaprini C, Cavazza A, Giurato L, et al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care. 2010;33(2):350-5.

Rosenbaum AJ, DiPreta JA. Classifications in Brief: Eichenholtz Classification of Charcot Arthropathy. Clin Orthop Relat Res. 2015;473:1168-71.

van der Ven A, Chapman CB, Bowker JH. Charcot neuroarthropathy of the foot and ankle. J Am Acad Orthop Surg. 2009;17(9):562-71.

Palestro CJ, Mehta HH, Patel M, Freeman JS, Harrington NW, Tomas BM, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998;39(2):346-50.

Tan P, James T. MRI of the diabetic foot: Differentiation of infection from neuropathic change. The British journal of radiology. 2007;80:939-48.

Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22(12):1707-12.

Mitchell EK, Richard JL. The Susceptible Insensate Foot. Clinical Prosthetics & Orthotics. 1988;12(2):61-6.

Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care. 2003;26(4):1164-9.

Güven MF, Karabiber A, Kaynak G, Oğüt T. Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabet Foot Ankle. 2013;4:10.

Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?. Diabet Med. 1994;11(1):28-31.

Jude EB, Selby PL, Burgess J. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44(11):2032-7.

Bem R, Jirkovská A, Fejfarová V, Skibová J, Edward B. Jude; Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial. Diabetes Care. 2006;29(6):1392-4.

Boulton AJ, Jeffcoate WJ, Jones TL, Ulbrecht JS. International collaborative research on Charcot’s disease. Lancet. 2009;373:105-6.

Papa J, Miyerson M, Girard P. Salvage with arthrodesis, intractable diabetic arthropathy of the foot and ankle. J Bone Joint Surg Am. 1993;82:1056-66.

Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000;82A:939-50.

Saltzman CL, Hagy ML, Zimmerman B, Estin M, Cooper R. How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?. Clin Orthop Relat Res. 2005;(435):185-90.






Case Reports